|
Clinical Proteomics Advances as Vermillion, LabCorp, Correlogic Prep Tests for Market
The nascent field of clinical proteomics got a big boost this week as several companies announced they have either begun marketing their proteomic-based ovarian cancer tests, or have moved closer to that goal.
(May 22, 2010)
Virginia Bioinformatics Institute Research Powerhouse Selects Conveys Hybrid-Core Computing Platform
Diverse Research Planned for Decision and Policy Informatics, Microsatellite Analysis, and Text Data Mining
(May 24, 2010)
Launch of GenoCon: First-ever Contest in Rational Genome Design Based on Semantic-web Technology
The Bioinformatics And Systems Engineering (BASE), a division of RIKEN, Japans flagship research institute, is holding its first ever International Rational Genome Design Contest (GenoCon) on the semantic web. The contest makes use of an information infrastructure for life science research known as the RIKEN Scientists Networking System (SciNeS*2) and will take place between May 25 and ...
(May 24, 2010)
Allen Institute for Brain Science launches Allen Human Brain Atlas
( Allen Institute for Brain Science ) The Allen Institute for Brain Science announced today that it has launched the Allen Human Brain Atlas, a publicly available online atlas charting genes at work throughout the human brain. The data provided in this initial data release represent the most extensive and detailed body of information about gene activity in the human brain to date, documenting ...
(May 24, 2010)
Proteomics International Hires 1st Base as Agent in Parts of Asia
NEW YORK (GenomeWeb News) Australian proteomics contract research organization Proteomics International said today it has hired 1st Base to be its exclusive agent in Singapore, Malaysia, Indonesia, and Thailand.
(May 24, 2010)
Virginia Bioinformatics Institute Research Powerhouse Selects Convey's Hybrid-Core Computing Platform
RICHARDSON, Texas----Dr. Harold Skip Garner, executive director of Virginia Bioinformatics Institute and Professor in the Department of Biological Sciences at Virginia Tech, pays close attention to the DNA of high-performance computing .
(May 24, 2010)
AB Sciex's New TripleTOF 5600 Debuts at ASMS, Allows Qualitative and Quantitative Analysis
AB Sciex has launched a new tool that for the first time will allow proteomics researchers to perform qualitative and quantitative research on the same platform.
(May 24, 2010)
France's Innopsys Says Array Scanner Sales Rose 25 Percent in '09; Firm Plans US Marketing Effort
Innopsys, a French microarray scanner and software maker , this week reported a 25-percent spike in 2009 receipts and a 30-percent increase in first-quarter sales.
(May 24, 2010)
Milk research group takes first step to functional ingredients
A new initiative to identify dairy bioactive ingredients has yielded 30 peptides that could be used to develop new functional food and beverage ingredients.
(May 25, 2010)
BGI Opens Branches in US, Denmark; to Invest $10M in Copenhagen Site during First Year
This article, originally published May 19, has been updated with information from Maqs Law Firm and BGI. Chinese genome center BGI has founded two branches, BGI Americas and BGI Europe, to offer research collaborations and services in sequencing and bioinformatics in those regions.
(May 25, 2010)
Workshop on protein engineering underway
A two-day workshop on the application of protein engineering and proteomics in molecular genetics began yesterday under the aegis of the research and training department of Shafallah Medical Genetics Center (SMGC).
(May 25, 2010)
Joint Study By Rosetta Genomics And NYU Langone Medical Center Identifies Potential MicroRNA Drug Target For ...
Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announced today that the results of a joint study with the NYU Langone Medical Center were published on May 12th, 2010 in the online issue of The Journal of Biological Chemistry. The study "Pro-tumorigenic Effects of miR-31 Loss in Mesothelioma," demonstrates the potential of miR-31 ...
(May 25, 2010)
Rutgers to Construct $55M Proteomics Building Where Existing Research Can Be Consolidated
Rutgers University will spend $55 million to construct a building for a new proteomics facility on its Piscataway, NJ, campus that will house NMR, X-ray crystallography, mass spectrometry, and computational biology resources.
(May 26, 2010)
Incyte Vies For Slice of High-Density Array Pie with New LifeArray Offerings
Until recently, Incyte''s microarray division positioned itself firmly in the content and service business. The company provided patented and proprietary gene content from its databases for other companies to spot down on microarrays, and also performed in-house microarraying for researchers.
(May 26, 2010)
Rosetta Genomics and Collaborators to Present New Data at ASCO 2010 on Clinical Studies Involving miRview mets
REHOVOT, Israel & PHILADELPHIA----Rosetta Genomics, Ltd. , a leading developer and provider of microRNA-based molecular diagnostic tests, announces new data from two studies using the Companys miRview mets test to predict the tissue of origin in patients with cancer of unknown primary site will be presented in a poster session and in the abstract book at the American Society of Clinical ...
(May 26, 2010)
Genentech uses Complete Genomics' human genome sequencing service to compare tumor and normal genome in patient with ...
( Complete Genomics ) Genentech used Complete Genomics' sequencing, bioinformatics and analytics services to sequence and compare a patient's primary lung tumor and adjacent normal tissue. Tumor-normal pairs like this allow researchers to compare the patient's genome before and after it was altered by the cancer; the patient's normal genome serves as the ideal control. This is the first time ...
(May 26, 2010)
In this issue of Pharmacogenomics Reporter
Picotti is developing a brand new targeted proteomics approach that she hopes will serve as an alternative to shotgun proteomics.
(May 26, 2010)
Rosetta Genomics Reports First Quarter 2010 Financial Results
PHILADELPHIA & REHOVOT, Israel----Rosetta Genomics, Ltd. , a leading developer of microRNA-based molecular diagnostics, today reported financial results for the three months ended March 31, 2010.
(May 26, 2010)
Danbury Hospital establishes Biomedical Research Center
Danbury Hospital has established a biomedical research center with a team of physician scientists whose members, the hospital says, are known for their groundbreaking work in the fields of cancer and proteomics.
(May 27, 2010)
Genentech uses Complete Genomics' sequencing service to compare primary lung tumor, adjacent normal tissue
Complete Genomics Inc., a third-generation human genome sequencing company, today announced that Genentech Inc., a wholly owned member of the Roche Group, used the company's sequencing, bioinformatics and analytics services to sequence and compare a patient's primary lung tumor and adjacent normal tissue.
(May 27, 2010)
This Week in Nucleic Acids Research
In Nucleic Acids Research this week, researchers in Paris evaluate splicing factor and exon expression profiles across 11 normal human tissues using microarray data.
(May 27, 2010)
Rosetta Genomics Reports Rise in Q1 Revenues Loss; Suspends Guidance
NEW YORK (GenomeWeb News) Rosetta Genomics today reported a slight rise in its first-quarter revenues and a 6 percent increase in its net loss year over year.
(May 27, 2010)
Complete Genomics' Human Genome Sequencing Service Used To Compare Tumor And Normal Genome In Patient With Non-Small ...
Complete Genomics Inc., a third-generation human genome sequencing company, has announced that Genentech Inc., a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), used the company's sequencing, bioinformatics and analytics services to sequence and compare a patient's primary lung tumor and adjacent normal tissue. Tumor-normal pairs like this allow researchers to compare the ...
(May 27, 2010)
Venter Says Synthetic Genomics May Speed Flu Vaccines (Update1)
Being able to create synthetic genes may enable companies such as Novartis AG to speed up development of flu vaccines as soon as next year, researcher J. Craig Venter said today at a congressional hearing.
(May 27, 2010)
Vermillion Reports $73K in Q1 Revenue After Posting No Revenue in 2009
Freemont, Calif.-based proteomics diagnostics firm Vermillion reported this week that it had first-quarter 2010 revenues of $73,000.
(May 28, 2010)
Eagle Genomics to Offer John Innes Centre's SNP-Analysis Software via Service Model
UK bioinformatics startup Eagle Genomics and the John Innes Centre are collaborating on a commercial bioinformatics service for plant breeding based on JIC's TraitTag SNP discovery software.
(May 28, 2010)
New Products
A number of vendors introduced new proteomics products at the American Society for Mass Spectrometry meeting in Salt Lake City this week. The following is a roundup of new offerings introduced at the conference.
(May 28, 2010)
Recent Research Papers of Note
Currently quantitative proteomics focuses mainly on measuring overall protein dynamics the net result of protein synthesis and degradation which is vital to understanding cellular dynamics and moving from transcriptome to proteome analysis.
(May 28, 2010)
U. of Chicago Joins National Clinical Genomics Initiative
NEW YORK, Dec. 3 - The University of Chicago said Monday it was joining the National Clinical Genomics Initiative, a partnership between clinical genomics company Ardais and several American medical institutions.
(May 29, 2010)
Building a House Where the Ground Moves Isn't Easy
Deepak links out to a paper published in BMC Bioinformatics that discusses 'omics software being developed at the Institute for Systems Biology. Their approach is to build a new framework where the software architecture integrates many different types of data and allows for the reuse of tools . Some themes are distributed applications, interoperability, and extensibility.
(May 29, 2010)
|
